ACR24 - JAK_TYK2
Rheumnow Podcast
00:00
Advancements in JAK Inhibitors for Inflammatory Diseases
This chapter explores recent advancements in the use of JAK inhibitors for conditions like giant cell arteritis and polymyalgia rheumatica, highlighting their efficacy and safety. It delves into clinical studies demonstrating the potential of these treatments, including their impact on refractory diseases and the role of cytokines. The chapter concludes with a discussion on cardiovascular risks associated with JAK inhibitors and the need for personalized treatment strategies.
Transcript
Play full episode
